These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10695477)

  • 1. A role of plasminogen in atherosclerosis and restenosis models in mice.
    Plow EF; Ploplis VA; Busuttil S; Carmeliet P; Collen D
    Thromb Haemost; 1999 Sep; 82 Suppl 1():4-7. PubMed ID: 10695477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemostatic factors occupy new territory: the role of the urokinase receptor system and kininogen in inflammation.
    Chavakis T; Kanse SM; May AE; Preissner KT
    Biochem Soc Trans; 2002 Apr; 30(2):168-73. PubMed ID: 12023845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine diphosphate receptor P2Y12-mediated migration of host smooth muscle-like cells and leukocytes in the development of transplant arteriosclerosis.
    Harada K; Matsumoto Y; Umemura K
    Transplantation; 2011 Jul; 92(2):148-54. PubMed ID: 21629176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis.
    Sata M; Saiura A; Kunisato A; Tojo A; Okada S; Tokuhisa T; Hirai H; Makuuchi M; Hirata Y; Nagai R
    Nat Med; 2002 Apr; 8(4):403-9. PubMed ID: 11927948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fcgamma receptor deficiency confers protection against atherosclerosis in apolipoprotein E knockout mice.
    Hernández-Vargas P; Ortiz-Muñoz G; López-Franco O; Suzuki Y; Gallego-Delgado J; Sanjuán G; Lázaro A; López-Parra V; Ortega L; Egido J; Gómez-Guerrero C
    Circ Res; 2006 Nov; 99(11):1188-96. PubMed ID: 17053192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smooth muscle migration in atherosclerosis and restenosis.
    Schwartz SM
    J Clin Invest; 1997 Dec; 100(11 Suppl):S87-9. PubMed ID: 9413408
    [No Abstract]   [Full Text] [Related]  

  • 7. Angiotensin II amplifies macrophage-driven atherosclerosis.
    Nobuhiko A; Suganuma E; Babaev VR; Fogo A; Swift LL; Linton MF; Fazio S; Ichikawa I; Kon V
    Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2143-8. PubMed ID: 15374850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urokinase plasminogen activator receptor promotes macrophage infiltration into the vascular wall of ApoE deficient mice.
    Gu JM; Johns A; Morser J; Dole WP; Greaves DR; Deng GG
    J Cell Physiol; 2005 Jul; 204(1):73-82. PubMed ID: 15573379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet P2Y(12) receptor influences the vessel wall response to arterial injury and thrombosis.
    Evans DJ; Jackman LE; Chamberlain J; Crosdale DJ; Judge HM; Jetha K; Norman KE; Francis SE; Storey RF
    Circulation; 2009 Jan; 119(1):116-22. PubMed ID: 19103996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic deletion or antibody blockade of alpha1beta1 integrin induces a stable plaque phenotype in ApoE-/- mice.
    Schapira K; Lutgens E; de Fougerolles A; Sprague A; Roemen A; Gardner H; Koteliansky V; Daemen M; Heeneman S
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1917-24. PubMed ID: 15976328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for a role of macrophage migration inhibitory factor in vascular disease.
    Chen Z; Sakuma M; Zago AC; Zhang X; Shi C; Leng L; Mizue Y; Bucala R; Simon D
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):709-14. PubMed ID: 14751814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasminogen activator inhibitor 1, fibrin, and the vascular response to injury.
    Fay WP
    Trends Cardiovasc Med; 2004 Jul; 14(5):196-202. PubMed ID: 15261892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The functions of plasminogen in cardiovascular disease.
    Plow EF; Hoover-Plow J
    Trends Cardiovasc Med; 2004 Jul; 14(5):180-6. PubMed ID: 15261889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid inflammatory mediators in diabetic vascular disease.
    Natarajan R; Nadler JL
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1542-8. PubMed ID: 15166011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of platelets in atherosclerosis and inflammation].
    Siegel-Axel D; Langer H; Lindemann S; Gawaz M
    Med Klin (Munich); 2006 Jun; 101(6):467-75. PubMed ID: 16767570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ablation of MEK kinase 1 suppresses intimal hyperplasia by impairing smooth muscle cell migration and urokinase plasminogen activator expression in a mouse blood-flow cessation model.
    Li Y; Minamino T; Tsukamoto O; Yujiri T; Shintani Y; Okada K; Nagamachi Y; Fujita M; Hirata A; Sanada S; Asanuma H; Takashima S; Hori M; Johnson GL; Kitakaze M
    Circulation; 2005 Apr; 111(13):1672-8. PubMed ID: 15795331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dextromethorphan reduces oxidative stress and inhibits atherosclerosis and neointima formation in mice.
    Liu SL; Li YH; Shi GY; Tang SH; Jiang SJ; Huang CW; Liu PY; Hong JS; Wu HL
    Cardiovasc Res; 2009 Apr; 82(1):161-9. PubMed ID: 19189960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial-dependent mechanisms of leukocyte recruitment to the vascular wall.
    Rao RM; Yang L; Garcia-Cardena G; Luscinskas FW
    Circ Res; 2007 Aug; 101(3):234-47. PubMed ID: 17673684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular functions of the plasminogen activation system.
    Fay WP; Garg N; Sunkar M
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1231-7. PubMed ID: 17379840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E.
    Huo Y; Schober A; Forlow SB; Smith DF; Hyman MC; Jung S; Littman DR; Weber C; Ley K
    Nat Med; 2003 Jan; 9(1):61-7. PubMed ID: 12483207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.